- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CIVITAS SOLUTIONS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 53,35 | -1,20 % | American Diversified Holdings Corporation: GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program | Del Mar, California--(Newsfile Corp. - November 25, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) announced today that GlucoGuard has completed the Level 2 App integration through... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,561 | -2,50 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ in Leptomeningeal Metastases | HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| CARDINAL HEALTH | 185,10 | +0,98 % | Neues Rekordhoch: Cardinal Health-Aktie klettert auf 208,34 USD | ||
| DAVITA | 104,15 | +0,43 % | DaVita: A Future Reimagined Through Choice, Trust and Empowerment | NORTHAMPTON, MA / ACCESS Newswire / November 25, 2025 / For Franz Nolan, hearing the words "kidney failure" brought back difficult memories. His father's long struggle with kidney disease made the idea... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| DENTSPLY SIRONA | 9,606 | +3,09 % | DENTSPLY SIRONA Inc. - 8-K, Current Report | ||
| CENTENE | 34,175 | +3,15 % | Why Centene Stock Just Popped | ||
| CYTOSORBENTS | 0,646 | -9,27 % | CytoSorbents in London: Wachstumspläne und Zulassungsstrategie | ||
| COOPER COMPANIES | 65,50 | -0,76 % | Browning West pushes Cooper Cos. board to appoint its directors | ||
| EKSO BIONICS | 4,270 | +1,67 % | Ekso Bionics Q2 2025 slides: Personal exoskeleton focus amid 58% revenue drop | ||
| FULGENT GENETICS | 26,600 | 0,00 % | Raymond James erhöht Kursziel für Fulgent Genetics nach starken Zahlen auf 36 US-Dollar | ||
| IMUNON | 3,320 | +1,22 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| DELCATH SYSTEMS | 8,100 | +1,25 % | Delcath Systems genehmigt Aktienrückkaufprogramm über 25 Millionen US-Dollar | ||
| CAREDX | 15,465 | -0,77 % | CareDx-Studie: Molekulare Tests verbessern Risikoprognose bei Herztransplantationen | ||
| NUWELLIS, INC | 2,240 | +5,16 % | Nuwellis, Inc.: Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum | MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing... ► Artikel lesen |
Das Unternehmen CIVITAS SOLUTIONS INC kann der Branche Gesundheitswesen zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIVITAS SOLUTIONS INC finden Sie auf Wallstreet Online.